🇺🇸 LNTH — Lantheus Holdings, Inc.

Salud Mantener
← Volver

Precio actual

100,61 USD

Máx. histórico

123,62

848 días

Caída desde máximo

-18,61%

Rango 52 semanas

50,16 – 111,86

Variación hoy

-0,09%

Cierre anterior

100,70

Rango de hoy

100,40 – 101,02

Volumen hoy

1.575.979

Peor caída histórica

-78,62%

17/08/2015 → 08/02/2016

Recuperado en 202 días

Volatilidad anualizada ⓘ

63,41%

Información
Nombre completo
Lantheus Holdings, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.193
PER ⓘ
25,03 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
106,99 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 5 horas
Sobre la empresa

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/08/2020 13,38 13,49 12,85 13,15 -1,87% 4,78% 490.000
20/08/2020 13,28 13,50 13,22 13,40 -0,45% 2,11% 388.500
19/08/2020 13,25 13,60 13,11 13,46 +1,82% 3,70% 497.800
18/08/2020 13,49 13,49 13,16 13,22 -2,07% 2,45% 373.500
17/08/2020 13,52 13,60 13,30 13,50 -0,30% 2,22% 376.700
14/08/2020 13,49 13,58 13,34 13,54 +0,07% 1,78% 295.000
13/08/2020 13,31 13,63 13,18 13,53 +0,00% 3,38% 388.300
12/08/2020 13,79 13,86 13,43 13,53 -1,10% 3,15% 488.600
11/08/2020 13,81 14,10 13,63 13,68 -0,51% 3,37% 453.200
10/08/2020 13,39 13,90 13,31 13,75 +3,46% 4,41% 537.700
07/08/2020 12,92 13,33 12,90 13,29 +2,00% 3,33% 618.500
06/08/2020 12,54 13,04 12,35 13,03 +3,41% 5,50% 997.000
05/08/2020 12,87 12,93 12,37 12,60 -0,47% 4,35% 1.372.000
04/08/2020 13,93 13,93 12,62 12,66 -4,81% 9,44% 994.100
03/08/2020 13,51 13,66 13,15 13,30 -1,34% 3,81% 923.300
31/07/2020 14,44 14,46 13,13 13,48 -7,99% 9,19% 1.600.300
30/07/2020 15,70 15,70 14,39 14,65 -6,75% 8,34% 670.200
29/07/2020 15,41 15,90 15,09 15,71 +2,88% 5,26% 501.200
28/07/2020 15,49 15,59 15,16 15,27 -2,05% 2,78% 665.000
27/07/2020 15,81 15,95 15,26 15,59 -1,27% 4,36% 427.800
24/07/2020 16,22 16,47 15,56 15,79 -3,37% 5,61% 453.800
23/07/2020 15,83 16,50 15,63 16,34 +3,48% 5,50% 706.600
22/07/2020 15,52 15,91 15,52 15,79 +1,61% 2,51% 461.300
21/07/2020 15,88 15,96 15,43 15,54 -0,64% 3,34% 918.200
20/07/2020 15,69 15,75 15,23 15,64 -0,70% 3,31% 559.600
17/07/2020 15,63 15,86 15,55 15,75 +0,51% 1,98% 404.200
16/07/2020 15,78 15,91 15,40 15,67 -0,76% 3,23% 433.100
15/07/2020 15,39 16,03 15,29 15,79 +5,34% 4,81% 806.300
14/07/2020 14,48 15,00 14,17 14,99 +3,81% 5,73% 554.900
13/07/2020 14,55 14,80 14,40 14,44 +0,14% 2,74% 486.700